CD8A and neoplasm: Rather than selecting specific tumor epitopes, whole tumor lysates represent a repertoire of tumor antigens to a patient’s immune system for the subsequent selection and expansion of pre-existing multiple tumor-specific CD8+ T-lymphocyte clones [53].